Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Shares Issued (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Shares Issued for 3 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 241.9% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.1 million through Dec 2025, up 1027.59% year-over-year, with the annual reading at $11.1 million for FY2025, 14681.95% up from the prior year.
  • Shares Issued for Q4 2025 was $1.8 million at bioAffinity Technologies, down from $6.5 million in the prior quarter.
  • The five-year high for Shares Issued was $6.5 million in Q3 2025, with the low at -$6.0 million in Q4 2022.
  • Average Shares Issued over 3 years is $560777.3, with a median of $1.2 million recorded in 2025.
  • Peak annual rise in Shares Issued hit 1463.66% in 2025, while the deepest fall reached 241.9% in 2025.
  • Over 3 years, Shares Issued stood at -$6.0 million in 2022, then skyrocketed by 78.69% to -$1.3 million in 2024, then surged by 241.9% to $1.8 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.8 million, $6.5 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.